✦ LIBER ✦

Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome

✍ Scribed by H. Lundh; O. Nilsson; I. Rosén; S. Johansson

Book ID: 118715421
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 508 KB
Volume: 88
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1993.tb04205.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3,4-Diaminopyridine (DAP) in the Treatme

3,4-Diaminopyridine (DAP) in the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

✍ DONALD B. SANDERS 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

3,4-Diaminopyridine in Lambert-Eaton Mya

3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis

✍ DONALD B. SANDERS; JAMES F. HOWARD JR; JANICE M. MASSEY 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

3,4-Diaminopyridine, an orphan drug, in

3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome

✍ J. Molgó, J. M. Guglielmi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 292 KB

Single-fiber electromyography improvemen

Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert–Eaton myasthenic syndrome

✍ Dae S. Kim; Gwendolyn C. Claussen; Shin J. Oh 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

The high incidence of elevated immunoglobulin (Ig)G anti-GQ1b antibody in sera from patients with acute phase Miller-Fisher syndrome (MFS) was first reported by Chiba et al. 1 and later confirmed by two other groups. 3,4 Chiba et al. 2 pointed out that anti-GQ1b IgG antibody is associated specifical

Neurogenic bladder in Lambert–Eaton myas

Neurogenic bladder in Lambert–Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

✍ Katsuya Satoh; Masakatsu Motomura; Hiroshi Suzu; Yoko Nakao; Takeshi Fujimoto; T 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Stimulated single-fiber electromyography

Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine

✍ Menachem Sadeh; Yaron River; Zohar Argov 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

A patient with LEMS unrelated to cancer was studied by ## CASE OF THE MONTH stimulated single-fiber electromyography (SFEMG) before and 3 months after the onset of therapy with 3,4-diaminopyridine. All end-plates showed Section Editors a progressive reduction in blockings and jitter with the incr